Explore HeberNasvac, a groundbreaking therapeutic vaccine for chronic Hepatitis B that empowers the immune system to fight the virus through innovative dual-antigen and dual-route approaches.
Exploring the impact of COVID-19 on hepatitis B patients through virological, clinical, and paraclinical aspects with data visualizations.
Discover how the HLA DRB1*15 allele influences hepatitis B susceptibility in Bangladeshi populations and the implications for personalized medicine.